本の詳細
形式
キンドル
ページ数
234
言語
英語
公開されました
Jan 31, 2020
出版社
Jim Gottstein Anchorage, Alaska USA
説明
On December 17, 2006, a significant revelation unfolded as The New York Times reported on newly uncovered documents linking the pharmaceutical company behind Zyprexa, an antipsychotic drug, to serious ethical concerns. This set of documents shed light on the company's practices and the potential dangers of their drug, particularly relating to its effects and marketing strategies.
The unfolding narrative in this collection delves into the complexities surrounding mental health treatment and the pharmaceutical industry, highlighting the struggles faced by patients and advocates. The authors, drawing from their diverse backgrounds, provide a powerful examination of how corporate interests can overshadow the well-being of individuals, urging readers to critically assess the implications of such practices on society at large.
The unfolding narrative in this collection delves into the complexities surrounding mental health treatment and the pharmaceutical industry, highlighting the struggles faced by patients and advocates. The authors, drawing from their diverse backgrounds, provide a powerful examination of how corporate interests can overshadow the well-being of individuals, urging readers to critically assess the implications of such practices on society at large.
ジャンル
児童書